Daniel Helbling

1.5k total citations
30 papers, 1.1k citations indexed

About

Daniel Helbling is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel Helbling has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 9 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel Helbling's work include Colorectal Cancer Treatments and Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Daniel Helbling is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Daniel Helbling collaborates with scholars based in Switzerland, Germany and Egypt. Daniel Helbling's co-authors include Hani Oweira, Anwar Giryes, Omar Abdel‐Rahman, Jan Schmidt, Arianeb Mehrabi, Othmar Schöb, Ulf Petrausch, Meinrad Mannhart, Haiko Sprott and Anne F. Mannion and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Spine.

In The Last Decade

Daniel Helbling

29 papers receiving 1.1k citations

Peers

Daniel Helbling
Ramazan Yıldız Türkiye
Uta Fischer Germany
Leszek Patrzałek Poland
Fengchun Zhang China
James A. Williams United States
Swan Sim Yeap Malaysia
Peter G. Compton United States
Helena Valta Finland
Siying Song China
Klaus Pietzner Germany
Ramazan Yıldız Türkiye
Daniel Helbling
Citations per year, relative to Daniel Helbling Daniel Helbling (= 1×) peers Ramazan Yıldız

Countries citing papers authored by Daniel Helbling

Since Specialization
Citations

This map shows the geographic impact of Daniel Helbling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Helbling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Helbling more than expected).

Fields of papers citing papers by Daniel Helbling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Helbling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Helbling. The network helps show where Daniel Helbling may publish in the future.

Co-authorship network of co-authors of Daniel Helbling

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Helbling. A scholar is included among the top collaborators of Daniel Helbling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Helbling. Daniel Helbling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pavone, Giuliana, Daniel Helbling, Saskia Hussung, et al.. (2023). Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients?. Cancers. 15(17). 4398–4398. 1 indexed citations
2.
April-Monn, Simon, Daniel Helbling, Massimo Falconi, et al.. (2022). Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects. Cancers. 14(22). 5481–5481. 5 indexed citations
3.
Siebenhüner, Alexander, Sara De Dosso, Daniel Helbling, et al.. (2021). Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement Article. Oncology Research and Treatment. 44(9). 485–494. 21 indexed citations
4.
Abdel‐Rahman, Omar, Hani Oweira, Ulf Petrausch, et al.. (2017). Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review. Expert Review of Anticancer Therapy. 17(4). 387–394. 118 indexed citations
5.
Eltobgy, Mostafa, Hani Oweira, Ulf Petrausch, et al.. (2017). Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review. Expert Review of Neurotherapeutics. 17(7). 725–736. 17 indexed citations
6.
Oweira, Hani, Ulf Petrausch, Daniel Helbling, et al.. (2017). Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis. World Journal of Gastroenterology. 23(10). 1872–1872. 129 indexed citations
7.
Oweira, Hani, Jan Schmidt, Daniel Helbling, et al.. (2017). Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review. Expert Review of Gastroenterology & Hepatology. 11(3). 1–10. 21 indexed citations
8.
Oweira, Hani, Ulf Petrausch, Daniel Helbling, et al.. (2017). Early stage hepatocellular carcinoma in the elderly: A SEER database analysis. Journal of Geriatric Oncology. 8(4). 277–283. 9 indexed citations
9.
Oweira, Hani, Ulf Petrausch, Daniel Helbling, et al.. (2017). Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma: a SEER database analysis. Expert Review of Gastroenterology & Hepatology. 11(7). 695–701. 37 indexed citations
10.
Abdel‐Rahman, Omar, Daniel Helbling, Othmar Schöb, et al.. (2016). P-241 Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma; an updated systematic review of 81 epidemiological studies. Annals of Oncology. 27. ii69–ii69. 1 indexed citations
11.
Abdel‐Rahman, Omar, Daniel Helbling, Jan Schmidt, et al.. (2016). Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis. Clinical Oncology. 29(4). 218–230. 44 indexed citations
12.
Abdel‐Rahman, Omar, Daniel Helbling, Jan Schmidt, et al.. (2016). Treatment-associated Fatigue in Cancer Patients Treated with Immune Checkpoint Inhibitors; a Systematic Review and Meta-analysis. Clinical Oncology. 28(10). e127–e138. 32 indexed citations
13.
Helbling, Daniel, G. Bodoky, Oliver Gautschi, et al.. (2012). Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07. Annals of Oncology. 24(3). 718–725. 59 indexed citations
14.
15.
Mannion, Anne F., Peter Schenk, Mark Gorelick, et al.. (2010). Ultrasound Tissue Doppler Imaging Reveals No Delay in Abdominal Muscle Feed-Forward Activity During Rapid Arm Movements in Patients With Chronic Low Back Pain. Spine. 35(16). 1506–1513. 34 indexed citations
16.
Mannion, Anne F., Daniel Helbling, N. Pulkovski, & Haiko Sprott. (2009). Spinal segmental stabilisation exercises for chronic low back pain: programme adherence and its influence on clinical outcome. European Spine Journal. 18(12). 1881–1891. 69 indexed citations
17.
18.
Helbling, Daniel, Beatrice U. Mueller, Nikolai A. Timchenko, et al.. (2004). The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin. Proceedings of the National Academy of Sciences. 101(36). 13312–13317. 71 indexed citations
19.
Helbling, Daniel, et al.. (2002). Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy. European Journal of Gastroenterology & Hepatology. 14(12). 1393–1395. 69 indexed citations
20.
Helbling, Daniel, Urs Boutellier, & Christina M. Spengler. (1997). Modulation of the ventilatory increase at the onset of exercise in humans. Respiration Physiology. 109(3). 219–229. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramazan Yıldız Breakdown of academic impact, for papers by Uta Fischer Breakdown of academic impact, for papers by Leszek Patrzałek Breakdown of academic impact, for papers by Fengchun Zhang Breakdown of academic impact, for papers by James A. Williams Breakdown of academic impact, for papers by Swan Sim Yeap Breakdown of academic impact, for papers by Peter G. Compton Breakdown of academic impact, for papers by Helena Valta Breakdown of academic impact, for papers by Siying Song Breakdown of academic impact, for papers by Klaus Pietzner
Rankless by CCL
2026